首页> 外国专利> Pharmaceutical composition comprising a Modulator device of a nicotinic receptor agonist, method for treating a disorder associated with a reduced transmission of nicotineMethod for identifying a nicotinic agonist repector, use a positive Modulator of an agonist recept

Pharmaceutical composition comprising a Modulator device of a nicotinic receptor agonist, method for treating a disorder associated with a reduced transmission of nicotineMethod for identifying a nicotinic agonist repector, use a positive Modulator of an agonist recept

机译:药物组合物,其包含烟碱样受体激动剂的调节剂装置,用于治疗与烟碱传递减少有关的病症的方法,用于鉴定烟碱样激动剂受体的方法,使用激动剂受体的阳性调节剂。

摘要

Pharmaceutical composition comprising a positive Modulator of a nicotinic receptor agonist (e.g., 5 - (5 - hidroxiindol IHO) together with pharmaceutically acceptable unportador,Taking the positive Modulator capable of increasing the effectiveness of the nicotinic receptor agonist.The methodof Treatment of a disorder associated with a reduced Transmission method for identifying nicotine, a nicotinic receptor agonist.Use of a nicotinic receptor agonist unmodulador positive in manufacrtura of a Medicament for the Treatment or prophylaxis of a disorder associated with transmission of nicotineReduced, in the manufacture of a Medicament for the treatment of Alzheimer's disease, Attention deficit hyperactivity disorder, Schizophrenia, Anxiety or Addiction to Nicotine.
机译:药物组合物,其包含烟碱样受体激动剂的正调节剂(例如5-(5--hidroxiindol IHO)以及药学上可接受的香port子,采取能够提高烟碱样受体激动剂的有效性的正调节剂。烟碱受体激动剂unmodulador阳性在药物制造中用于治疗或预防与尼古丁传播有关的疾病的用途减少,在制备用于治疗的药物中的用途痴呆,注意力不足过动症,精神分裂症,焦虑症或尼古丁成瘾。

著录项

  • 公开/公告号AR016217A1

    专利类型

  • 公开/公告日2001-06-20

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号AR1999P101861

  • 发明设计人

    申请日1999-04-22

  • 分类号A61K31/405;A61P25/18;A61P25/14;A61P25/26;

  • 国家 AR

  • 入库时间 2022-08-22 01:26:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号